Meeting Banner
Abstract #0997

In Vivo Detection of Alzheimer Disease in APP Transgenic Mice with T2-Mapping

Maximilian N. Voelker1, Stephan Roeskam2, Alexander M. Koenig1, Richard Dodel2, Johannes T. Heverhagen1

1Diagnostic Radiology, Philipps University, Marburg, Hessen, Germany; 2Department of Neurology, Philipps University, Marburg, Germany

Alzheimer disease can be detected by MRI in APP transgenic mice by T2-Mapping without the need for contrast agent or high resolution imaging. in vivo Alzheimer plaques imaging on transgenic mice is challenging because of small plaques size (20 - 70m), long measurement duration and limitation to ultra high fields (>7T). Indirect measurement of plaque load with T2-Mapping allows faster protocols and differentiation between APP- transgenic mice and wild type mice. Strong effects on T2 have been detected due to accumulation of iron in plaques.

Keywords

accumulation achieve addition adjusted agent agents already analyzed animal animals anterior array automated background better biggest body brain brains breakers breathing calculation carefully chem cognitive coil considered consisted contrast control cored cortex cortical deficits defined dense deposition deposits designed detected detection deviation diagnostic discarding disease double duration earlier early encode enhanced evident examined example expressing field five form gender gene gives head hypothesis in vivo insular internal iron isotropic jack lateral living load long loss mapping maps matched measure measured mice model monitored monitoring month mouse mutant need neuritic neurology noise nuclei nucleus older onset pathogenesis pathology plague plaque plaques positive posterior potential power precursor promoter protein protocol radiology reduction related resolution robust scanner sensory setup shortening simple slices software specially statistical steady strong stronger strongest subtracting supports temperature therapy tool treatment various ventral week whole window